Abstract
The concept of presynaptic receptors modulating the release of neurotransmitters has arisen from studies on peripheral noradrenergic neurons (Langer, 1974, 1981, Starke, 1981), and has now been extended to the central nervous system for several neurotransmitters, such as noradrenaline, serotonin, acetylcholine and dopamine. It is possible to differentiate between presynaptic inhibitory autoreceptors, acted upon by transmitters which can regulate their own release and in some cases their synthesis, and presynaptic heteroreceptors sensitive to endogenous compounds other than the neuron’s own transmitter. Such substances include co-transmitter neuropeptides, transmitters released from adjacent terminals, or locally or blood-borne substances which can facilitate or inhibit the calcium-dependent release of the neurotransmitter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Airaksinen, M.M. and Kari, I. (1981). B-Carbolines, psychoactive compounds in the mammalian body. Med. Biol., 59, 190–211.
Barbaccia, M.L. and Costa, E. (1984). Autocoids for drug receptors a new approach in drug development. New York Acad. Sci., 430, 103–114.
Barbaccia, M.L., Gandolfi, O., Chuang, D.M. and Costa, E. (1983). Modulation of neuronal 5HT uptake by a putative endogenous ligand of imipramine recognition sites. Proc. Natl. Acad. Sci. USA, 80, 5134–5138.
Baumann, P.A. and Waldmeier, P.C. (1981). Further evidence for negative feed-back control of serotonin release in the central nervous system. Naunyn-Schmiedeberg’s Arch. Pharmacol., 317, 3643.
Bradley, P.B., Engel, G., Feniuk, W., Fozard, J.R., Humphrey, P.P.A., Middlemiss, D.N., Mylecharane, E.J., Richardson, B.P. and Saxena, P.R. (1986). Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology, 25, 563–576.
Cerrito, F. and Raiteri, M. (1979). Serotonin release is modulated by presynaptic autoreceptors. Eur. J. Pharmacol., 57, 427–430.
Chaput, Y., de Montigny, C. and Blier, P. (1986). Effects of a selective 5HT reuptake blocker, citalopram, on the sensitivity of 5HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg’s Arch. Pharmacol., 333, 342–348.
Engel, G., Göthert, M., Moyer, D., Schlicker, E. and Hillenbrand, K. (1986). Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5HT1B binding sites. Naunyn-Schmiedeberg’s Arch. Pharmacol., 332, 1–7.
Farnebo, L.O. and Hamberger, B. (1974). Regulation of [3H]5-hydrox ytr yptamine release from rat brain slices. J. Pharm. Pharmacol., 26, 642–644.
Galzin, A.M. and Langer, S.Z. (1986). Potentiation by deprenyl of the autoreceptor-mediated inhibition of [H]-5-hydroxytryptamine release by 5-methoxytryptamine. Naunyn-Schmiedeberg’s Arch. Pharmacol., 333, 330–333.
Galzin, A.M., Eon, M.T., Esnaud, H., Lee, C.R., PĂ©vet, P. and Langer, S.Z. Day-night rhythm of 5-methox ytryptamine levels in the pineal gland of the Golden Hamster (Mesocricetus auratus). Endocrinology, submitted.
Galzin, A.M., Moret, C., Verzier, B. and Langer, S.Z. (1985). Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus. J. Pharmacol. Exp. Ther., 235, 200–211.
Göthert, M. (1982). Modulation of serotonin release in the brain via presynaptic receptors. Trends in Pharmacol. Sci., 3, 437–440.
Göthert, M. and Weinheimer, G. (1979). Extracellular 5-hydroxytryptamine inhibits 5-hydrox ytryptamine release from rat brain cortex slices. Naunyn-Schmiedeberg’s Arch. Pharmacol., 310, 93–96.
Habert, E., Graham, D., Tahraoui, L., Claustre, Y. and Langer, S.Z. (1985). Characterization of [3H]-paroxetine binding to rat cortical membranes. Eur. J. Pharmacol., 118, 107–114.
Hamon, M., Bourgoin, S., Jagger, J. and Glowinski, J. (1974). Effects of LSD on synthesis and release of 5-HT in rat brain slices. Brain Res., 69, 265–280.
Kamal, L., Arbilla, S., Galzin, A.-M. and Langer, S.Z. (1983). Agiphetamine inhibits the electrically evoked release of [33H]dopamine from slices of the rabbit caudate. J. Pharmacol. Exp. Ther., 227, 446–458.
Kari, I. (1981). 6-Methoxy-1,2,3,4-tetrahydro-B-carboline in pineal gland of chicken and cock. FEBS Lett., 127, 277–280.
Kari, I., Airaksinen, M.M., Gynther, J. and Huhtikangas, A. (1983). Mass spectrometric identification of 6-methoxy-1,2,3,4-tetrahydro-B-carboline in pineal gland. In Recent developments in biochemistry, medicine and environmental research. (ed. A. Frigerio). 8, Elsevier, Amsterdam.
Langer, S.Z. (1974). Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 23, 1793–1800.
Langer, S.Z. (1981). Presynaptic regulation of the release of catecholamines. Pharmacol. Rev., 32, 337–362.
Langer, S.Z. (1984). [3H]imipramine and [3H]desipramine binding non-specific displaceable sites or physiologically relevant sites associated with the uptake of serotonin and noradrenaine? Trends in Pharmacol. Sci., 5, 51–52.
Langer, S.Z. and Moret, C. (1982). Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus. J. Pharmacol. Exp. Ther., 222, 220–226.
Langer, S.Z. and Raisman, R. (1983). Binding of [3H]imipramine and [H]desipramine as biochemical tools for studies in depression. Neuropharmacology, 22, 407–413.
Langer, S.Z., Briley, M.S., Raisman, R., Henry, J.F. and Morselli, P.L. (1980a). Specific 3H-imipramine binding in human platelets: influence of age and sex. Naunyn-Schmiedeberg’s Arch. Pharmacol., 313, 189–194.
Langer, S.Z., Lee, C.R., Schoemaker, H., Segonzac, A. and Esnaud, H. (1985). 5-Methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site. In Endocoids. (eds. H. Lal, F. Labella and J. Lane). Alan R. Liss, New York, pp. 441–455.
Langer, S.Z., Lee, C.R., Segonzac, A., Tateishi, T., Esnaud, H., Schoemaker, H. and Winblad, B. (1984b). Possible endocrine role of the pineal gland for 6-methoxytetrahydro-beta-carboline, a putative endogenous neuromodulator of the [H]imipramine recognition site. Eur. J. Pharmacol., 102, 379–380.
Langer, S.Z., Moret, C., Raisman, R., Dubocovich, M.L. and Briley, M.S. (1980b). High-affinity [3H]imipramine binding in rat hypothalamus is associated with the uptake of serotonin but not norepinephrine. Science, 210, 1133–1135.
Unger, S.Z., Raisman, R. and Briley, M.S. (1981a). High-affinity [H]DMI binding is associated with neuronal noradrenaline uptake in the periphery and the central nervous system. Eur. J. Pharmacol., 72, 423–424.
Langer, S.Z., Raisman, R., Tahraoui, L., Scatton, B., Niddam, R., Lee, C.R. and Claustre, Y. (1984a). Substituted tetrahydro-B- c~rbolines are possible candidates as endogenous ligand of the [H]imipramine recognition site. Eur. J. Pharmacol., 98, 153–154.
Langer, S.Z., Galzin, A.M., Lee, C.R. and Schoemaker, H. (1986) Antidepressant binding sites in brain and platelets In Antidepressants and receptor function Ciba Foundation Symposium 123, John Wiley and Sons, pp. 3–29.
Langer, S.Z., Zarifian, E., Briley, M.S., Raisman, R. and Sechter, D. (1981b). High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders. Life Sci., 29, 211–218.
Leino, M., Kari, I., Airaksinen, M.M. and Gynther, J. (1983). 6-Methoxy-tetrahydro-B-carboline in the retinae of rabbits and pigs. Exp. Eye Res., 36, 135–138.
Lewis, D.A. and McChesney, C. (1985). Tritiated imipramine binding distinguishes among subtypes of depression. Arch. Gen. Psychiatry, 42, 485–488.
Maura, G. and Raiteri, M. (1984). Functional evidence that chronic drugs induce adaptive changes of central autoreceptors regulating serotonin release. Eur. J. Pharmacol., 97, 309–313.
Paul, S.M., Rehavi, M., Skolnick, P., Ballenger, J.C. and Goodwin, F.K. (1981). Depressed patients have decreased binding of tritiated imipramine to the platelets serotonin “transporter”. Arch. Gen. Psychiatry, 38, 1315–1317.
Passarelli, F., Galzin, A.M. and Langer, S.Z. Interaction between neuronal uptake inhibitors and presynaptic serotonin autoreceptors in rat hypothalamic slices: comparison of K+ and electrical depolarization. J. Pharmacol. Exp. Ther., submitted.
Pelayo, F., Dubocovich, M.L. and Langer, S.Z. (1980). Inhibition of neuronal uptake reduces the presynaptic effects of clonidine but nqt of a-methylnoradrenaline on the stimulation-evoked release of [H]-noradrenaline from rat occipital cortex slices. Eur. J. Pharmacol., 64, 143–155.
Pettibone, D.J. and Pflueger, A.B. (1984). Effects of methiothepin and lysergic acid diethylamide on serotonin release in vitro and serotonin synthesis in vivo. possible relation to serotonin autoreceptor function. J. Neurochem., 43, 83–90.
Pévet, P. (1983). Is 5-methoxytryptamine a pineal hormone? Psychoneuroendocrinology, 8, 61–73.
Poirier, M.F., Benkelfat, C., Loo, H., Sechter, D., Zarifian, E., Galzin, A.M. and Langer, S.Z. (1986). Reduced BB, of [3H]-imipramine binding to platelets of depressed patientg-free of previous medication with 5HT uptake inhibitors. Psychopharmacol., 89, 456–461.
Raisman, R., Briley, M.S., Bouchami, F., Sechter, D., Zarifian, E. and Langer, S.Z. (1982b). 3H-Imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers. Psychopharmacol., 77, 332–335.
Raisman, R., Sette, M., Pimoule, C., Briley, M.S. and Langer, S.Z. (1982a). High affinity [3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline. Eur. J. Pharmacol., 78, 345–351.
Schlicker, E., Brandt, F., Classen, K. and Gthert, M. (1985). Serotonin release in human cerebral cortex and its modulation via serotonin receptors. Brain Res., 331, 337–341.
Schoemaker, H., Pimoule, C., Arbilla, S., Scatton B., Javoy-Agid, F. and Langer S.Z. (1985). Sodium-dependent [H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinson’s disease. Naunyn-Schmiedeberg’s Arch. Pharmacol., 329, 227–235.
Segonzac, A., Schoemaker, H., Tateishi, T. and Langer, S.Z. (1985). 5-Methoxytryptoline, a competitive endocoid acting at 3H-imipramine recognition sites in human platelets. J. Neurochem., 45, 249–256.
Verg€, D., Daval, G., Patey, A., Gozlan, H., El-Mestikawy, S. and Hamon, M. (1985). Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5HTIA subtype. Eur. J. Pharmacol., 113, 463–464.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 The Wenner-Gren Center
About this chapter
Cite this chapter
Langer, S.Z., Galzin, AM. (1987). Different Presynaptic Receptors Modulate Neuronal Uptake and Transmitter Release in Serotoninergic Nerve Terminals. In: Fuxe, K., Agnati, L.F. (eds) Receptor-Receptor Interactions. Wenner-Gren Center International Symposium Series. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5415-4_30
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5415-4_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5417-8
Online ISBN: 978-1-4684-5415-4
eBook Packages: Springer Book Archive